Hematological Malignancies

Progression Free Survival of 131I Rituximab vs Last qualifying chemotherapy. Illidge et al Blood 2009

100

80

RIT

60

40

% Relapse free

20

CT/ICT

0

0

1

2

3

4

5

Time in Years

3 13

1 7

0 6

0 4

0 0

A B 16

16